These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6410909)

  • 41. Systemic effects of rectally administered corticosteroids.
    Reshef R; Varkel J; Shiller M; Loberant N
    Isr J Med Sci; 1992 Feb; 28(2):98-100. PubMed ID: 1559805
    [No Abstract]   [Full Text] [Related]  

  • 42. Treatment of distal ulcerative colitis: now the patients have the choice.
    Schölmerich J
    Ital J Gastroenterol Hepatol; 1999 Nov; 31(8):685-7. PubMed ID: 10730560
    [No Abstract]   [Full Text] [Related]  

  • 43. Retrograde spread of hydrocortisone containing foam given intrarectally in ulcerative colitis.
    Farthing MJ; Rutland MD; Clark ML
    Br Med J; 1979 Oct; 2(6194):822-4. PubMed ID: 509112
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gonadotrophin releasing hormone surge during pro-oestrus: role of steroid hormones [proceedings].
    Fink G; Sarkar DK; Chiappa SA
    J Endocrinol; 1977 Dec; 75(3):47P-48P. PubMed ID: 338858
    [No Abstract]   [Full Text] [Related]  

  • 45. A case of steroid refractory ulcerative colitis treated with cyclosporin.
    Sreenivas DV; Kumar A; Kumar YR; Satyanarayana G
    Trop Gastroenterol; 1997; 18(1):26. PubMed ID: 9197170
    [No Abstract]   [Full Text] [Related]  

  • 46. Roentgenographic reversibility of ulcerative colitis in children treated with steroid enemas.
    Goldberg HI; Carbone JV; Margulis AR
    Am J Roentgenol Radium Ther Nucl Med; 1968 Jun; 103(2):365-79. PubMed ID: 5656232
    [No Abstract]   [Full Text] [Related]  

  • 47. Effects of tixocortol pivalate on gastrointestinal disease in systemic mastocytosis: a preliminary study.
    Friedman BS; Metcalfe DD
    Clin Exp Allergy; 1991 Mar; 21(2):183-8. PubMed ID: 2043986
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Beclomethasone dipropionate (3 mg) enemas combined with oral 5-ASA (2.4 g) in the treatment of ulcerative colitis not responsive to oral 5-ASA alone.
    D'Arienzo A; Manguso F; Castiglione GN; Vicinanza G; Scaglione G; Bennato R; Sanges M; Mazzacca G
    Ital J Gastroenterol Hepatol; 1998 Jun; 30(3):254-7. PubMed ID: 9759590
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Low Pentasa dosage versus hydrocortisone in the topical treatment of active ulcerative colitis: a randomized, double-blind study.
    Bianchi Porro G; Ardizzone S; Petrillo M; Fasoli A; Molteni P; Imbesi V
    Am J Gastroenterol; 1995 May; 90(5):736-9. PubMed ID: 7733079
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mesalazine foam (Salofalk foam) in the treatment of active distal ulcerative colitis. A comparative trial vs Salofalk enema. The SAF-3 study group.
    Ardizzone S; Doldo P; Ranzi T; Sturniolo GC; Giglio LA; Annese V; D'Arienzo A; Gaia E; Gullini S; Riegler G; Valentini M; Massa P; Del Piano M; Rossini F; Guidetti CS; Pera A; Greinwald R; Bianchi Porro G
    Ital J Gastroenterol Hepatol; 1999 Nov; 31(8):677-84. PubMed ID: 10730559
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Systemic absorption from hydrocortisone foam enema in ulcerative colitis.
    Cann PA; Holdsworth CD
    Lancet; 1987 Apr; 1(8538):922-3. PubMed ID: 2882324
    [No Abstract]   [Full Text] [Related]  

  • 52. Neoral may be as effective as intravenous cyclosporine in the treatment of steroid-resistant ulcerative colitis.
    Oppong K; Record CO
    Am J Gastroenterol; 1998 Jul; 93(7):1188-9. PubMed ID: 9672369
    [No Abstract]   [Full Text] [Related]  

  • 53. The management of ulcerative colitis.
    Watkinson G; De Dombal FT
    Scott Med J; 1968 Apr; 13(4):133-43. PubMed ID: 4297824
    [No Abstract]   [Full Text] [Related]  

  • 54. Combined oral and topical mesalazine treatment for extensive ulcerative colitis.
    Moss AC; Cheifetz AS; Peppercorn MA
    Nat Clin Pract Gastroenterol Hepatol; 2006 May; 3(5):290-3. PubMed ID: 16673009
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Delayed hypersensitivity reactions to corticosteroids applied to mucous membranes.
    Bircher AJ; Pelloni F; Langauer Messmer S; Müller D
    Br J Dermatol; 1996 Aug; 135(2):310-3. PubMed ID: 8881682
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Pivalone and vasomotor rhinitis].
    Bebear JP; Bagot d'Arc M
    Rev Laryngol Otol Rhinol (Bord); 1984; 105(3):321-2. PubMed ID: 6484351
    [No Abstract]   [Full Text] [Related]  

  • 57. [The use of an oil emulsion of oxycort in chronic colitis].
    Matabeli GV
    Klin Med (Mosk); 1968 Jul; 46(7):99-102. PubMed ID: 5715098
    [No Abstract]   [Full Text] [Related]  

  • 58. [Hydrocortisone-17-butyrate (0.1 percent) versus hydrocortisone acetate (1 percent) in atopic dermatitis. Controlled double-blind study of 20 children].
    Giannetti A; Laria G; Seidenari S
    Minerva Pediatr; 1981 Jun; 33(12):597-600. PubMed ID: 7022158
    [No Abstract]   [Full Text] [Related]  

  • 59. [Acute adrenal insufficiency after stopping prolonged corticotherapy with betnesol enemas for ulcerative colitis].
    Bili H; Algayres JP; Revel F; Coutant G; Daly JP
    Gastroenterol Clin Biol; 1998 Dec; 22(12):1113-4. PubMed ID: 10051992
    [No Abstract]   [Full Text] [Related]  

  • 60. Tixocortol pivalate: what is the right concentration?
    Kalavala M; Statham BN; Green CM; King C; Ormerod AD; Sansom J; English JS; Wilkinson MS; Horne H; Gawkrodger D
    Contact Dermatitis; 2007 Jul; 57(1):44-6. PubMed ID: 17577357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.